It’s often said that companies saved money on trips not taken during the pandemic — as though they had a choice — and didn’t suffer much. But some outcomes show how not traveling can take a toll on operations, revenue generation and due diligence. Travel restrictions “severely limited” a clinical trial for pharmaceutical company BrainStorm Cell Therapeutics. They mucked up…
Before starting The Company Dime with David Jonas in 2014, journalist Jay Campbell a decade earlier created travel business newsletter The Beat. In 2006, Jay co-founded Travel Procurement magazine and in 2010 helped integrate them with Business Travel News. He served as BTN's editorial director until 2013. Jay made his travel industry media debut in 1993 at the Air Travel Journal of Boston while earning his undergraduate degree in journalism at Boston University. He would be happy to connect on LinkedIn. He's here at CorporateTravel.social on Mastodon.
